cross-posted from: https://community.nicfab.it/post/24571
On December 28, 2022, the Spanish Data Protection Authority (“AEPD”) published a statement on the interplay between its recently approved Spanish code of conduct for the pharmaceutical industry and the European Federation of Pharmaceutical Industries and Associations’ (“EFPIA”) proposal for an EU code of conduct on clinical trials and pharmacovigilance. The statement relates specifically to the legal basis for processing personal data in the context of clinical trials.
You must log in or register to comment.